期刊文献+

0.5%左氧氟沙星与0.3%加替沙星及0.3%乳酸左氧氟沙星的房水药物浓度研究 被引量:4

Human aqueous humor levels of levofloxacin 0. 5 %, gatifloxacin 0. 3% and levofloxacin 0. 3% ophthalmic solution after topical dosing
原文传递
导出
摘要 目的探讨人眼分别滴用0.5%左氧氟沙星、0.3%加替沙星及0.3%乳酸左氧氟沙星后房水中药物浓度差异。方法采用随机、双盲、平行研究方法。选取2006年8月至2007年2月在浙江大学医学院附属第二医院眼科中心预行白内障超声乳化术的老年白内障患者150例(150只单侧眼),使用随机数字表法分为3个大组:0.5%左氧氟沙星组(50只眼)、0.3%加替沙星组(50只眼)、0.3%乳酸左氧氟沙星组(50只眼),每个大组再使用随机排列表分为5个亚组,每个亚组10只眼。按不同大组,术前分别局部给予0.5%左氧氟沙星、0.3%加替沙星或0.3%乳酸左氧氟沙星滴眼,总共4次,每次间隔15min。手术时按不同亚组,分别于最后1次给药后15、30、60、120、180min时抽取房水多于100μl,然后用加样器准确定量至100μl置于带塞试管中。全部标本采用高效液相色谱法测定房水中药物浓度。采用单因素方差分析(ANOVA)对不同时间点的3种药物浓度进行统计学分析,两两之间差异比较采用t检验进行分析。结果给药后15、30、60、120、180min房水内0.5%左氧氟沙星浓度(1.61±0.48)、(2.41±0.80)、(2.93±0.50)、(2.56±0.63)、(1.87±0.88)mg/L分别高于对应时间点的0.3%加替沙星浓度(0.70±0.18)、(1.29±0.54)、(1.59±0.67)、(1.41±0.50)、(1.13±0.28)mg/L及0.3%乳酸左氧氟沙星浓度(0.55±0.39)、(1.15±0.42)、(1.38±0.49)、(1.02±0.33)、(0.55±0.31)mg/L,差异均有统计学意义(F=23.64,12.82,21.13,25.00,12.22;P均〈0.05)。0.3%加替沙星和0.3%乳酸左氧氟沙星的房水药物浓度经检验在15、30、60、120min无明显差异(t=1.09,0.68,0.83,2.00;均P〉0.05)。在180min时0.3%加替沙星的房水药物浓度高于0.3� Objective To compare the aqueous humor concentration of levofloxacin 0. 5%, gatifloxacin 0. 3% and levofloxacin 0. 3% ophthalmic solution after topical dosing in human eyes. Methods A randomized, double-blind and parallel study was conducted. Senile cataract patients (150 eyes in 150 cases) receiving phacoemulsification in eye center affiliated second hospital of Zhejiang university were randomized into three groups: levofloxacin 0. 5%, 50 eyes; gatifloxacin 0. 3%, 50 eyes and levofloxacin 0. 3% ,50 eyes. Each group was randomized into five sub-groups ,with 10 eyes in each sub-group. Each group received either levofloxacin 0. 5% or topical gatifloxacin 0. 3% or levofloxacin 0. 3% preoperatively. One drop of antibiotic was administered every 15 minutes for 4 doses. More than 100 μl aqueous samples were obtained from different sub-groups during surgery,15.0,30. 0,60. 0, 120.0 and 180. 0 min after the last drop,respectively. Then 100 μl aqueous samples were put into test tube by sample injector accurately. Concentration of the antimicrobial agents was determined by the HPLC ( high pressure liquidchromatography). Variance analysis was performed to detect differences among the antibiotic treatment groups. The differences between two groups were assumed by t-test. Results Humor concentration of levofloxacin 0. 5% ( 1.61 ± 0. 48 ), ( 2.41 ±0. 80 ), ( 2. 93 ± 0. 50 ), ( 2. 56± 0. 63 ), ( 1.87±0. 88 ) mg/L was significantly higher than that of gatifloxacin 0. 3% ( 0. 70± 0. 18 ), ( 1.29 ± 0. 54 ), ( 1.59 ± 0. 67 ), (1.41±0.50),(1.13 ±0.28 )mg/L and levofloxacin0.3% (0.55±0.39),(1.15 ±0.42),(1.38 ± 0.49), ( 1.02 ± 0. 33 ), (0. 55 ± 0. 31 ) mg/L at the same period after the last drop ( F = 23.64,12. 82, 21.13,25.00,12. 22 ;P 〈 0. 05 ). Conclusion Topically applied levofloxacin 0. 5% had the higher aqueous humor drug level than gatifloxacin 0. 3% and levofloxacin 0. 3%.
出处 《中华眼科杂志》 CAS CSCD 北大核心 2009年第11期987-991,共5页 Chinese Journal of Ophthalmology
关键词 眼房水 氧氟沙星 荧光喹诺酮类 眼药水 色谱法 高压液相 Aqueous humor Ofloxacin Fluoroquinolones Ophthalmic solutions Chromatography, high pressure liquid
  • 相关文献

参考文献13

  • 1Koch HR, Kulus SC, Roessler M, et al. Corneal penetration of fluoroquinolones: aqueous humor concentrations after topical application of levofloxacin 0.5% and ofloxacin 0.3% eyedrops. J Cataract Refract Surg, 2005, 31:1377-1385. 被引量:1
  • 2Smith A, Pennefather PM, Kaye SB, et al. Fluoroquinolones: place in ocular therapy. Drugs,2001,61:747-761. 被引量:1
  • 3姚克,章征,杨瑶华,吴筱丹.人眼滴用氧氟沙星和环丙沙星及妥布霉素的前房穿透性研究[J].中华眼科杂志,2003,39(12):736-739. 被引量:23
  • 4Emst ME, Ernst EJ, Klepser ME. Levofloxacin and Trvafloxacin: the next generation of Fluoroquinolones. Am J Health Syst Pharm, 1997.54:69-84. 被引量:1
  • 5Wimer SM, Schoonover L, Garrison ME. Levofloxacin: therapeutic review. Clin Ther, 1998,20 : 1049-1070. 被引量:1
  • 6Schwab IR, Friedlaender M, McCulley J, et al. A phase Ⅲ clinical tray of 0. 5% Levofloxacin ophthalmic solution versus 0.3% Ofloxacin ophthalmic solution for the treatment of bacterial conjunctivitis. Ophthalmology, 2003,110:457465. 被引量:1
  • 7Kawashima Y, Takashina H, Usui M. Pharmacokinetic parameters of ofloxacin and levofloxacin ophthalmic solutions. Atarashii Ganka, 1995,12:791-794. 被引量:1
  • 8Kawazu K, Takahashi H, Kawashima Y, et al. Effect of pH on the ocular penetration of levofloxacin. Atarashii Ganka, 1996,13 : 259-262. 被引量:1
  • 9Healy DP, Holland EJ, Nordlund ML, et al. Concentrations of Levofloxacin, Ofloxacin, and Ciprofloxacin in human corneal stromal tissue and aqueous humor after topical administration. Cornea, 2004,23:255-263. 被引量:1
  • 10Kawazu K, Midori Y, Shiono H, et al. Charaeterizatio of the carrier-mediated transport of levofloxacin, a fluoroquinolone antimicrobial agent, in rabbit cornea. J Pharm Pharmacol, 1999, 51:797-801. 被引量:1

二级参考文献25

  • 1Ellerhost B,Golden B,Jarudi N.Ocular penetration of topically applied gentamicin.Arch Ophthalmol,1975,93:371-378. 被引量:1
  • 2Ke TL,Cagle G,Schlech B,et al.Ocular bioavailability of ciprofloxacin in sustained release formulations.J Ocul Pharmacol Ther,2001,17:555-563. 被引量:1
  • 3Schoenwald RD,Boltralik JJ.A bioavailability comparison in rabbits of two steroids formulated as high-viscosity gels and reference aqueous preparations.Invest Ophthalmol Vis Sci,1979,18:61-66. 被引量:1
  • 4Schoenwald R.Ocular drug delivery.Clin Pharmacokinet,1990,18:255-269. 被引量:1
  • 5Callegan MC,Booth MC,Gilmore MS.In vitro pharmacodynamics of ofloxacin and ciprofloxacin against common ocular pathogens.Cornea,2000,19:539-545. 被引量:1
  • 6Wimer SM,Schoonover L,Garrison MW.Levofloxacin:a therapeutic review.Clin Therapeut,1998,20:1049-1070. 被引量:1
  • 7Osher RH;Amdahl LD;Cheetham JK.Antimicrobial efficacy and aqueous humor concentration of preoperative and postoperative topical trimethoprim/polymyxin B sulfate versus tobramycin,1994. 被引量:1
  • 8Smith A;Pennefather PM;Kaye SB.Fluoroquinolones:place in ocular therapy[J],2001(6). 被引量:1
  • 9Sunaric-Megevand G;Pournaras CJ.Current approach to postoperative endophthalmitis[J],1997. 被引量:1
  • 10Kresloff MS;Castellarin AA;Zarbin MA.Endophthalmitis[J],1998(3). 被引量:1

共引文献24

同被引文献26

引证文献4

二级引证文献26

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部